Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Ortho clinical diagnostics (ocd) internal testing has confirmed the potential for lower than expected vitros c-reactive protein (crp) results from samples diluted with vitros specialty diluent or vitros fs diluent pack 3. when using the affected lots ocd found that results using vitros crp slides may be negatively biased by approximately 51% using a 3x dilution factor.